Investors seeking amplified daily exposure to U.S. large-cap equities often evaluate leveraged products that differ in benchmark construction. HIBL and SPXL both deliver 3x daily returns but target distinct segments of the S&P 500 universe. They do not compete directly as substitutes; instead, they represent alternative leveraged strategies for investors with similar bullish outlooks but varying risk tolerances and views on market leadership. This comparison highlights structural distinctions that influence their behavior across market environments.
HIBL seeks daily investment results, before fees and expenses, of 300% of the S&P 500 High Beta Index. The index selects the 100 stocks from the S&P 500 with the highest beta over the prior 12 months and weights them accordingly. The ETF typically holds around 99 securities, with notable concentration in technology names that exhibit elevated volatility. Its expense ratio stands at 0.98%. As a leveraged product from Direxion, HIBL utilizes swaps and other derivatives for daily reset exposure and is designed for short-term tactical use rather than buy-and-hold strategies.
SPXL aims for 300% of the daily performance of the S&P 500 Index. It provides leveraged exposure to 500 large-cap U.S. companies weighted by market capitalization. The fund maintains roughly 500 holdings, with top positions reflecting the broad index leaders. Its expense ratio is 0.84%. Like its counterpart, SPXL employs daily resetting through financial instruments and is intended for sophisticated investors monitoring short-term market movements.
Both ETFs operate within the U.S. large-cap equity space amid ongoing sector rotations driven by technology innovation, interest-rate expectations, and macroeconomic data. High-beta segments have benefited from periods of risk-on sentiment and growth leadership, while the broader S&P 500 has captured steady contributions from established mega-cap firms. Capital flows into leveraged products often accelerate during earnings seasons or policy shifts, though regulatory scrutiny of daily-reset products remains a background consideration for market participants.
In recent weeks and months, HIBL has demonstrated greater sensitivity to momentum shifts within high-volatility names, amplifying gains during technology-led advances but also magnifying drawdowns. SPXL has provided more proportional tracking of overall large-cap performance, with lower relative volatility stemming from its diversified holdings. Over recent market cycles, the high-beta focus of HIBL has aligned with stronger responses to earnings surprises in cyclical sectors, whereas SPXL has reflected steadier participation across defensive and growth areas alike.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.
Based on structural strength, cost efficiency, and broader diversification, Tickeron’s AI would currently assign a higher probability of suitability to SPXL for investors seeking leveraged large-cap exposure with relatively lower idiosyncratic risk. The fund’s lower expense ratio and comprehensive S&P 500 coverage provide a more balanced profile across varying market regimes compared with the concentrated high-beta approach of HIBL.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HIBL saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In 90 of the 94 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HIBL turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 59 similar instances when the indicator turned negative. In 55 of the 59 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
HIBL moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIBL crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIBL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The RSI Indicator entered the oversold zone -- be on the watch for HIBL's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIBL advanced for three days, in 307 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
HIBL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 262 of 285 cases where HIBL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
On October 21, 2026, the Stochastic Oscillator for SPXL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 54 instances where the indicator left the oversold zone. In 49 of the 54 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
The 10-day moving average for SPXL crossed bullishly above the 50-day moving average on September 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +2.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPXL advanced for three days, in 326 of 356 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 338 of 367 cases where SPXL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPXL as a result. In 63 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for SPXL turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In 48 of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
SPXL moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
| HIBL | SPXL | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | N/A |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 86% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Declines ODDS (%) | 9 days ago 88% | 15 days ago 88% |
| BollingerBands ODDS (%) | 1 day ago 90% | N/A |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
A.I.dvisor indicates that over the last year, HIBL has been closely correlated with ETN. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIBL jumps, then ETN could also see price increases.
| Ticker / NAME | Correlation To HIBL | 1D Price Change % | ||
|---|---|---|---|---|
| HIBL | 100% | -14.53% | ||
| ETN - HIBL | 74% Closely correlated | -6.33% | ||
| BLK - HIBL | 73% Closely correlated | -1.07% | ||
| CAT - HIBL | 70% Closely correlated | -4.89% | ||
| FBIN - HIBL | 70% Closely correlated | +6.94% | ||
| FIX - HIBL | 68% Closely correlated | -8.70% | ||
More | ||||
A.I.dvisor indicates that over the last year, SPXL has been loosely correlated with MSFT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPXL jumps, then MSFT could also see price increases.
| Ticker / NAME | Correlation To SPXL | 1D Price Change % | ||
|---|---|---|---|---|
| SPXL | 100% | -3.60% | ||
| MSFT - SPXL | 63% Loosely correlated | -2.23% | ||
| AAPL - SPXL | 62% Loosely correlated | +1.23% | ||
| AMZN - SPXL | 60% Loosely correlated | -4.57% | ||
| META - SPXL | 59% Loosely correlated | -6.98% | ||
| NVDA - SPXL | 56% Loosely correlated | -4.40% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XPH | 64.28 | 0.32 | +0.50% |
| State Street SPDR S&P Pharmaceuticals ETF (XPH) | |||
| BRHY | 49.26 | 0.10 | +0.19% |
| iShares High Yield Active ETF (BRHY) | |||
| DGOC | 33.04 | -0.12 | -0.38% |
| FT Vest U.S. Equity Buffer & Digital Return ETF - October (DGOC) | |||
| MLPA | 53.79 | -0.23 | -0.43% |
| Global X MLP ETF (MLPA) | |||
| SEPT | 38.45 | -0.31 | -0.80% |
| AllianzIM U.S. Equity Buffer10 Sep ETF (SEPT) | |||